Top member reports
Consensus community valuation
$1.500
Average Intrinsic Value
971.4%
Undervalued by
Active Member Straws
#Bull Case
Last edited 4 months ago

Cellmid is a Company of two halves being 1, Advandgen Hair Growth 2. Midkine Diagnostic and therapeutic cancer treatments. this has already been outsourced to Pacific Edge. Lyramid the 100% wholly owned subsidiary holds these assets and going to be spun off once an agreement has been made with a development partner.  Current MC is very cheap with several imminent triggers for a re-rate.

Adding to the bull case Cellmid will likely advise the market that the a licensee to import and distribute Covid-19 15 minute tests. Currently in Suspension, CDY will likely open much higher. Potential revenue figures are significant

Read More